The collection of functional, somatic and germline MMR testing data as part of the NCRD provides ongoing opportunities for (i) audit of guideline adherence, (ii) review of future diagnostic pathway changes and (iii) research into endometrial and LS cancer outcomes. The gene discussed is MRC1; the disease is Leigh syndrome.